In a 43‑year‑old woman with iron‑deficiency anemia who has started oral iron therapy, when should the iron studies and complete blood count (CBC) be repeated?

Timing of Follow-up Testing for Iron Deficiency Anemia on Oral Iron

Repeat CBC at 2 weeks to confirm response (hemoglobin rise ≥10 g/L), then recheck both CBC and iron studies at 8-10 weeks to assess treatment adequacy.

Initial Response Assessment (2 Weeks)

The most critical early checkpoint is at 2 weeks after starting oral iron therapy. At this point, check only the CBC, specifically hemoglobin 1.

• A hemoglobin rise of at least 10 g/L (1 g/dL) at 2 weeks is strongly predictive of successful treatment (sensitivity 90.1%, specificity 79.3%) 1
• Failure to achieve this increment signals likely treatment failure and requires investigation for:
  • Non-adherence (often due to GI side effects)
  • Malabsorption
  • Ongoing blood loss exceeding iron intake
  • Incorrect diagnosis (concurrent B12/folate deficiency, bone marrow pathology, hemolysis)

This early checkpoint prevents wasting months on ineffective therapy and allows prompt escalation to parenteral iron if needed.

Complete Reassessment (8-10 Weeks)

At 8-10 weeks, perform comprehensive testing including both CBC and iron studies (ferritin, transferrin saturation) 2. This timeframe allows:

• Assessment of hemoglobin normalization (target ≥12 g/dL for women)
• Evaluation of iron store repletion (ferritin should be rising toward >30 µg/L)
• Decision-making about continuation or modification of therapy

The AGA guideline notes that response to oral iron is typically evident within 1 month 3, which aligns with the 8-10 week comprehensive reassessment rather than requiring earlier iron studies.

Common Pitfalls to Avoid

1. Don't wait months without any monitoring - Recent real-world data shows only 15.1% of patients receive appropriate follow-up 4, leading to prolonged untreated anemia

2. Don't recheck ferritin too early (before 8 weeks) - ferritin rises more slowly than hemoglobin, and premature testing may falsely suggest treatment failure

3. Don't ignore the 2-week checkpoint - this is your earliest opportunity to identify non-responders and prevent treatment delays

4. Remember to exclude inflammation - if ferritin appears adequate but patient isn't responding, check CRP to rule out false elevation from acute phase reaction 2

Long-term Monitoring

For patients who achieve normalization but have risk factors for recurrence (heavy menstrual bleeding, malabsorption, dietary insufficiency):

• Repeat basic blood tests every 6-12 months to monitor iron stores 2
• Consider intermittent oral supplementation to maintain stores in high-risk patients
• Never continue daily iron supplementation long-term once ferritin normalizes - this is potentially harmful 2

The British Society of Gastroenterology emphasizes that whatever regimen you choose, "it is essential to monitor the initial haematological response, and modify as appropriate with apparent therapeutic failure" 1. The 2-week and 8-10 week checkpoints provide this structured monitoring framework.